Indonesia's Bio Farma aims to submit interim review on Sinovac vaccine in January

A health worker holds up a vial containing Sinovac's Covid-19 candidate vaccine on Aug. 8, 2020 at the Sao Lucas Hospital in Porto Alegre, Brazil.- Reuters

JAKARTA (The Jakarta Post Jakarta/ANN): PT Bio Farma has announced that the state-owned pharmaceutical company plans to submit its interim results from the third and final trial phase of the Sinovac vaccine to the Indonesian Food and Drug Monitoring Agency (BPOM) in January 2021.

The interim report is to include the results of the phase three clinical trials of the vaccine conducted in China and Brazil, which started prior to the trials in Indonesia.